Pangburn Receives Business Leadership Award
Charlie Pangburn, chief legal officer for University of Cincinnati Physicians, will be recognized with the Walter R. Dunlevy/Frontiersman Award at the Northern Kentucky Chamber of Commerces annual dinner on Sept. 13, 2011. Established in 1968, the award recognizes an individual who has a lifelong history of outstanding service to the Northern Kentucky community and the nominee's profession or industry, and who exemplifies the highest standards of personal integrity.
Prior to joining University of Cincinnati Physicians, Pangburn served as associate general counsel at the University of Cincinnati. His experience also includes 20 years of private law practice, including serving as a founding member of the 14-attorney firm of Hemmer Pangburn DeFrank PLLC in Fort Mitchell, Ky. and as a partner in Taft, Stettinius & Hollister, LLP in Cincinnati.
An active member of the Northern Kentucky community, he has served as commissioner and vice chairman of the Northern Kentucky Convention and Visitors Bureau, chairman of the Northern Kentucky Consensus Committee, chairman of the Northern Kentucky Chamber of Commerce, board member for The Point/ARC of Northern Kentucky, co-chair of Vision 2015 Governance Action Team and on the board of directors for the Tri-County Economic Development Corporation. He is the recipient of the Dan Beard Council Citizenship Award and the Walter L. Pieschel "Volunteer of the Year award from the Northern Kentucky Chamber of Commerce.
A retired Colonel, Pangburns 30 years of active and reserve service in the U.S. Marine Corps included a combat tour in Iraq in 2004. His personal decorations include the Legion of Merit, the Bronze Star Medal, two awards of the Meritorious Service Medal and four awards of the Navy and Marine Corps Commendation Medal.
Tags
Related Stories
Cancer Center plays key role in lab research, clinical trials for new pancreatic cancer drug
September 1, 2026
WLWT and WCPO highlighted the contributions of University of Cincinnati Cancer Center researchers that helped lead to the recent FDA approval of daraxonrasib, a new treatment for pancreatic cancer.
Cancer Center physician receives $150,000 New Investigator Research Grant to study treatment-resistant leukemia
September 1, 2026
The University of Cincinnati Cancer Center’s Sarah Skuli, MD, PhD, received a two‑year, $150,000 Leukemia Research Foundation New Investigator Grant to study TP53‑mutated leukemia, a treatment‑resistant subtype with very poor outcomes.
Heavy social media use linked to depression
August 31, 2026
U.S. News and World Report, Yahoo! News, MSN, USA Today and other national media highlight a new study by the University of Cincinnati and Northwestern University that found a correlation between heavy social media use and depression in adults.